OPEN END TURBO OPTIONSSCHEIN SHORT - ROCHE GS Share Price

Certificat

DE000GG0MHS7

Real-time BOERSE MUENCHEN 05:56:49 27/06/2024 pm IST
3.03 EUR -1.94% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - ROCHE GS
Current month-37.58%
1 month-37.58%
Date Price Change
27/24/27 3.03 -1.94%
26/24/26 3.09 +17.49%
25/24/25 2.63 +1.94%
24/24/24 2.58 -7.19%
21/24/21 2.78 -10.32%

Real-time BOERSE MUENCHEN

Last update June 27, 2024 at 05:56 pm IST

More quotes

Static data

Product typeKnock-Out sin Stop Loss
Buy / SellPUT
Underlying ROCHE HOLDING AG
Issuer Goldman Sachs
WKN GG0MHS
ISINDE000GG0MHS7
Date issued 04/12/2023
Strike 279.4 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 5.3
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 7.006
Lowest since issue 2.58
Spread 0.02
Spread %0.66%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
249.6 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.40%
Consensus